# OnCo record verify (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/verify/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "verify", "NCT05210790" ;
  schema:name "VERIFY"@en ;
  schema:alternateName "verify"@en ;
  schema:description "VERIFY showed that weekly rusfertide, a hepcidin mimetic, freed most PV patients from phlebotomy and improved their symptoms, leading to the drug's approval in 2026."@en ;
  schema:url <https://onco.cc/trials/verify/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05210790> ;
  onco:status "positive" ;
  onco:tag "polycythaemia-vera", "mpn" ;
  onco:phase "3" ;
  schema:startDate "2022-04-01" ;
  onco:cancers <https://onco.cc/cancers/polycythaemia-vera/>, <https://onco.cc/cancers/myeloproliferative-neoplasms/> ;
  onco:technologies <https://onco.cc/technologies/peptide-drug-conjugate/> ;
  onco:drugs <https://onco.cc/drugs/rusfertide/> ;
  onco:companies <https://onco.cc/companies/protagonist-therapeutics/>, <https://onco.cc/companies/takeda/> .